Abstract
Estramustine phosphate has been used for over 20 years in the treatment of advanced prostate cancer. Recent reports of promising results from clinical combination studies, and neoadjuvant studies, have caused a renewed interest in this relatively old drug. After oral or intravenous administration, estramustine phosphate is metabolised to four main metabolites: estramustine, estromustine, estradiol and estrone. Due to the potential biological activity of all these estramustine phosphate metabolites, it is necessary to analyse the parent compound and all four metabolites in plasma, tissues and tumours. Consequently, various methods have been developed for the bioanalysis of these compounds. In this review various methods are described for the analysis of estramustine phosphate and its metabolites in biological fluids and tissues. Methods described included RIA, TLC, HPLC, HPLC-MS, GC and GC-MS.
Keywords: nor-nitrogen mustard conjugate, prostate cancer, plasma clearance, bioavailability, high first-pass metabolism, non-chromatographic assay procedure, estradiol, chromatography, spectrometry, estrone
Current Pharmaceutical Analysis
Title: A Short Review of Analytical Methods for the Determination of Estramustine Phosphate and its Metabolites in Biological Samples
Volume: 1 Issue: 2
Author(s): Massimo Breda and Christopher A. James
Affiliation:
Keywords: nor-nitrogen mustard conjugate, prostate cancer, plasma clearance, bioavailability, high first-pass metabolism, non-chromatographic assay procedure, estradiol, chromatography, spectrometry, estrone
Abstract: Estramustine phosphate has been used for over 20 years in the treatment of advanced prostate cancer. Recent reports of promising results from clinical combination studies, and neoadjuvant studies, have caused a renewed interest in this relatively old drug. After oral or intravenous administration, estramustine phosphate is metabolised to four main metabolites: estramustine, estromustine, estradiol and estrone. Due to the potential biological activity of all these estramustine phosphate metabolites, it is necessary to analyse the parent compound and all four metabolites in plasma, tissues and tumours. Consequently, various methods have been developed for the bioanalysis of these compounds. In this review various methods are described for the analysis of estramustine phosphate and its metabolites in biological fluids and tissues. Methods described included RIA, TLC, HPLC, HPLC-MS, GC and GC-MS.
Export Options
About this article
Cite this article as:
Breda Massimo and James A. Christopher, A Short Review of Analytical Methods for the Determination of Estramustine Phosphate and its Metabolites in Biological Samples, Current Pharmaceutical Analysis 2005; 1 (2) . https://dx.doi.org/10.2174/1573412054022716
DOI https://dx.doi.org/10.2174/1573412054022716 |
Print ISSN 1573-4129 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-676X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Is Tretinoin Still a Key Agent for Photoaging Management?
Mini-Reviews in Medicinal Chemistry Angiogenesis Inhibition: State of the Art, Forgotten Strategies and New Perspectives in Cancer Therapy
Current Cancer Therapy Reviews Novel Therapeutic Strategies for Dementia
CNS & Neurological Disorders - Drug Targets Polyphenols: Potential Future Arsenals in the Treatment of Diabetes
Current Pharmaceutical Design Despite an Extensive Sequence Analysis Identification of Functional Candidates Amongst Hypothetical Proteins of Neisseria gonorrhoeae
Letters in Drug Design & Discovery The Influence of Cox-2 and Bioactive Lipids on Hematological Cancers
Current Angiogenesis (Discontinued) Exosomes and Lung Cancer: Roles in Pathophysiology, Diagnosis and Therapeutic Applications
Current Medicinal Chemistry Targeting Focal Adhesion Kinase in Neuroblastoma
Anti-Cancer Agents in Medicinal Chemistry Effects of Snake Venom Polypeptides on Central Nervous System
Central Nervous System Agents in Medicinal Chemistry Longitudinal Melatonin Production in Female Laboratory Rats During 1997-2006: Possible Modulatory Effects of Changing Solar Activity
Current Aging Science Fragment-based Discovery of Potential Anticancer Lead: Computational and in vitro Studies
Current Computer-Aided Drug Design MicroRNAs as Cancer Biomarkers
MicroRNA Fork Head Transcription Factors
Current Genomics Expression and Prognostic Significance of the MMP Family Molecules in Bladder Cancer
Combinatorial Chemistry & High Throughput Screening ω-3 Polyunsaturated Fatty Acids Effects on the Cardiometabolic Syndrome and their Role in Cardiovascular Disease Prevention: An Update from the Recent Literature
Recent Advances in Cardiovascular Drug Discovery (Discontinued) Telomere Maintenance as Therapeutic Target in Embryonal Tumours
Anti-Cancer Agents in Medicinal Chemistry Prostate Cancer Prevention in the Developing World - What are we Waiting for?
Current Pharmacogenomics and Personalized Medicine Identification of the ZAK-MKK4-JNK-TGFβ Signaling Pathway as a Molecular Target for Novel Synthetic Iminoquinone Anticancer Compound BA-TPQ
Current Cancer Drug Targets Disruption of Circadian Rhythms and Delirium, Sleep Impairment and Sepsis in Critically ill Patients. Potential Therapeutic Implications for Increased Light-Dark Contrast and Melatonin Therapy in an ICU Environment
Current Pharmaceutical Design Editorial (Thematic Issue: Crosstalk Between the Nervous and the Immune Systems in Health and Sickness)
Current Pharmaceutical Design